Discriminative stimulus properties of nicotine: Approaches to evaluating potential nicotinic receptor agonists and antagonists

Drug Development Research

Volumn 38, Issue 3-4, 1996, Pages 222-230

  Wiley, Jenny L ^a   James, John R ^a   Rosecrans, John A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

ABT 418; Discrimination; Epibatidine; Nicotine; Review

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ARECOLINE; ATROPINE; EPIBATIDINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLATROPINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; GENETIC VARIABILITY; HUMAN; NONHUMAN; RAT; SMOKING; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030445892     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199607/08)38:3/4<222::AID-DDR11>3.0.CO;2-0     Document Type: Article

References (52)

1. 3H]ABT-418: A novel cholinergic channel ligand. J Pharmacol Exp Ther 273:1434-1441.
2. Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS, Wasicak JT, Williams M (1994): (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities. I. In vitro characterization. J Pharmacol Exp Ther 270:310-318.
3. Balster RL (1990): Perception of drug effects. In Berkley MA, Stebbins WC (eds): Comparative Perception: Basic Mechanisms. New York: John Wiley & Sons, pp. 127-154.
4. Brioni JD, Kim DJB, Brodie MS, Decker MW, Arneric SP (1995): ABT-418: Discriminative stimulus properties and effect on ventral tegmental cell activity. Psychopharmacology 119:368-375.
5. Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992): The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285-289.
6. Damaj MI, Creasy KR, Grove AD, Rosecrans JA, Martin BR (1994a): Pharmacological effects of epibatidine optical isomers. Brain Res 664:34-40.
7. Damaj MI, Welch SP, Martin BR (1994b): Nicotine-induced anti-nociception in mice: Role of G-proteins and adenylate cyclase. Pharmacol Biochem Behav 48:37-42.
8. Damaj MI, Creasy KR, Welch SP, Rosecrans JA, Aceto MD, Martin BR (1995): Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Psychopharmacology 120:483-490.
9. Decker MW, Brioni JD, Bannon AW, Americ SP (1995): Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics. Life Sci 56:545-570.
10. Gilbert DG, Gilbert BO (1995): Personality, psychopathology, and nicotine response as mediators of the genetics of smoking. Behav Genet 25:133-147.
11. Gordon TL, Meehan SM, Schlechter MD (1993): P and NP rats respond differently to the discriminative stimulus effects of nicotine. Pharmacol Biochem Behav 45:305-308.
12. 3H]dopamine release from mouse striatal synaptosomes. J Neurochem 62:1390-1398.
13. Hendry JS, Rosecrans JA (1982): Effects of nicotine on conditioned and unconditioned behaviors in experimental animals. Pharmacol Ther 17:431-454.
14. 3H]Epibatidine binding to nicotinic cholinergic receptors in brain. Med Chem Res 4:538-546.
15. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
16. Iwamoto ET (1989): Antinociception after nicotine administration in the mesopontine tegmentum of rats: Evidence for muscarinic actions. J Pharmacol Exp Ther 251:412-421.
17. James JR, Villanueva HF, Johnson JH, Arezo S, Rosecrans JA (1994): Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors. Psychopharmacology 114: 456-462.
18. Jarvik ME (1991): Beneficial effects of nicotine. Br J Addiction 86:571-575.
19. Jones RA (1986): Individual differences in nicotine sensitivity. Addictive Behav 11:435-438.
20. Kallman NM, Kallman MJ, Harry GJ, Woodson PP, Rosecrans JA (1982): Nicotine as a discriminative stimulus in human subjects. In Colpaert FC, Slangen JL, (eds): Drug Discrimination: Application in CNS Pharmacology. Amsterdam: Elsevier Biomedical Press, pp 211-218.
21. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith BJ (1993): Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology 111:259-270.
22. Levin ED (1992): Nicotinic systems and cognitive function. Psychopharmacology 108:417-431.
23. Lumeng L, Hawkins TD, Li TK (1977): New strains of rats with alcohol preference and nonpreference. In Thurman RG, Williamson JR, Drott H, Chance B (eds): Alcohol and Aldehyde Metabolizing Systems. New York: Academic Press, Vol 3, pp 537-544.
24. Marks MJ, Burch JB, Collins AC (1983): Effects of chronic nicotine infusion on tolerance development and cholinergie receptors. J Pharmacol Exp Ther 224:806-816.
25. Martin BR, Martin TJ, Fan F, Damaj MI (1993): Central actions of nicotine antagonists. Med Chem Res 2:564-577.
26. Overstreet DH (1995): Differential effects of nicotine in inbred and selectively bred rodents. Behav Genet 25:179-185.
27. Overstreet DH (1993): The Flinders Sensitive line rats: A genetic animal model of depression. Neurosci Biobehav Res 17:51-68.
28. Overstreet DH, Russell RW, Helps SC, Messenger M (1979): Selective breeding for sensitivity to the anticholinesterase, DFP. Psychopharmacology 65:15-20.
29. Perkins KA (1995): Individual variability in responses to nicotine. Behav Genet 25:119-132.
30. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL (1994): Nicotine discrimination in male and female smokers. Psychopharmacology 116:407-413.
31. Rosecrans JA (1971): Effects of nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. Eur J Pharmacol 14:29-37.
32. Rosecrans JA (1989): Nicotine as a discriminative stimulus: A neurobiobehavioral approach to studying central cholinergic mechanisms. J Subst Abuse 1:287-300.
33. Rosecrans JA (1995): The psychopharmacological basis of nicotine's differential effects on behavior: Individual subject variability in the rat. Behav Genet 25:187-196.
34. Rosecrans JA, Glennon RA (1979): Drug-induced cues in studying mechanisms of drug action. Neuropharmacology 18:981-989.
35. Rosecrans JA, James JR (1993): The evaluation of central cholin ergic neurons using an in vivo drug discrimination paradigm in rats. Med Chem Res 2:530-545.
36. Rosecrans JA, Meltzer LT (1981): Central sites and mechanisms of action of nicotine. Neurosci Biobehav Rev 6:489-497.
37. Rosecrans JA, Villanueva HF (1991): Discriminative stimulus properties of nicotine: Mechanisms of transduction. In Glennon RA, Järbe TUC, Frankenheim J (eds): Drug Discrimination: Applications to Drug Abuse Research (pp. 101-116). NIDA Research Monograph 116. Washington DC: U.S. Department of Health and Human Services.
38. Rosecrans JA, Karan LD, James JR (1995): Nicotine as a discriminative stimulus: Individual variability to acute tolerance and the role of receptor desensitization. In Clarke PBS, Quik M, Adlkofer F, Thurau K (eds): Advances in Pharmacological Sciences: Effects of Nicotine on Biological Systems. Basel: Birkhauser Verlag, Vol II, pp 219-223.
39. Rowell PP, Hillebrand JA (1994): Characterization of nicotine-induced desensitization of evoked dopamine release from rat striatal synaptosomes. J Neurochem 63:561-569.
40. Russell RW, Overstreet DH (1987): Mechanisms underlying sensitivity to organophosphorus anticholinesterase agents. Prog Neurobiol 28:97-129.
41. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989): The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797-800.
42. Schechter MD, Rosecrans JA (1971): C.N.S. effect of nicotine as the discriminative stimulus for the rat in a T-maze. Life Sci 10:821-832.
43. Schechter MD, Rosecrans JA (1972): Nicotine as a discriminative cue in rats: Inability of related drugs to produce a nicotine-like cueing effect. Psychopharmacology 27:379-387.
44. Schwartz RD, Lehman J, Kellar KJ (1984): Presynaptic nicotinic receptors labelled by 3H-acetylcholine on catecholamine and serotonin neurons in brain. J Neurochem 42:1495-1498.
45. Stolerman IP, Jarvis MJ (1995): The scientific case that nicotine is addictive. Psychopharmacology 117:2-10.
46. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R (1983): Nicotine cue in rats analyzed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology 22: 1029-1037.
47. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984): Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413-419.
48. Sullivan JP, Briggs D, Donnelly-Roberts D, Brioni JD, Radek RJ, McKenna DG, Campbell JE, Arneric SP, Decker MW, Bannon AW (1994): (±)-Epibatidine can differentially evoke responses mediated by putative subtypes of nicotinic acetylcholine receptors (nAChRs). Med Chem Res 4:502-516.
49. Takada K, Swedberg MD, Goldberg SR, Katz JL (1989): Discriminative stimulus effects of intravenous l-nicotine and nicotine analogs or metabolites in squirrel monkeys. Psychopharmacology 99:208-212.
50. Varvel SA, James JR, Karan LD, Bowen SE, Rosecrans JA (1996): Nicotine as a discriminative stimulus in the mouse. Submitted.
51. Warburton DM (1992): Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 16:181-191.
52. Wonnacott S, Drasdo A, Sanderson E, Rowell P (1990): Presynaptic nicotinic receptors and the modulation of transmitter release. In Bock G, Marsh J (eds): The Biology of Nicotine Dependence. Chichester: Wiley, pp 87-105.